Early research shows that editing expanding trinucleotide repeats halts the lengthening process that causes neurological ...

Biogen and City Therapeutics, a privately held developer of RNA-based “trigger molecules,” announced a partnership to develop ...

Gene Weaver, a Cambridge Cluster biotech innovator, has received $515,214 from the Gates Foundation to support the ...

The protein DNase1 is one of the oldest biological agents in history. It has been on the market since 1958 and is now used, ...

The personalized CRISPR treatment could be the future of gene therapy, but hurdles remain before everyone has access.

The administration's cuts at the National Institutes of Health will obliterate billions in economic gains, America's ...

The companion animal vaccines products market is expected to reach USD 3,964.7 million by 2025 and is expected to steadily grow at a CAGR of 4.2% to reach USD 5,982.7 million by 2035. In 2024, ...

Shuttle-based therapies are under active development for an array of brain conditions. “It’s now abundantly clear that we can ...

The FDA has placed a clinical hold on the study while Rocket works with trial monitors and experts to investigate the cause ...

The human organism is far too complex and unpredictable to program like a computer and optimize for longevity.